Unum Group (NYSE:UNM) Stock Holdings Lifted by Atomi Financial Group Inc.

Atomi Financial Group Inc. lifted its position in Unum Group (NYSE:UNM) by 20.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,525 shares of the financial services provider’s stock after acquiring an additional 770 shares during the period. Atomi Financial Group Inc.’s holdings in Unum Group were worth $330,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. boosted its holdings in shares of Unum Group by 8.5% during the fourth quarter. UMB Bank n.a. now owns 4,084 shares of the financial services provider’s stock worth $298,000 after purchasing an additional 319 shares during the period. Polianta Ltd acquired a new stake in shares of Unum Group during the fourth quarter worth approximately $1,241,000. HB Wealth Management LLC boosted its holdings in shares of Unum Group by 56.7% during the fourth quarter. HB Wealth Management LLC now owns 5,928 shares of the financial services provider’s stock worth $433,000 after purchasing an additional 2,146 shares during the period. Merit Financial Group LLC acquired a new stake in shares of Unum Group during the fourth quarter worth approximately $328,000. Finally, Boston Common Asset Management LLC boosted its holdings in shares of Unum Group by 19.6% during the fourth quarter. Boston Common Asset Management LLC now owns 69,278 shares of the financial services provider’s stock worth $5,059,000 after purchasing an additional 11,373 shares during the period. 86.57% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Unum Group

In other news, EVP Elizabeth Claire Ahmed sold 5,000 shares of the stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $64.16, for a total value of $320,800.00. Following the completion of the transaction, the executive vice president now owns 58,741 shares in the company, valued at approximately $3,768,822.56. This represents a 7.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $76.92, for a total transaction of $769,200.00. Following the completion of the transaction, the executive vice president now owns 54,827 shares of the company’s stock, valued at approximately $4,217,292.84. This represents a 15.43 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 107,914 shares of company stock worth $7,998,745 in the last ninety days. 0.93% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on UNM. Evercore ISI upgraded shares of Unum Group from an “in-line” rating to an “outperform” rating and raised their price target for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. BMO Capital Markets began coverage on shares of Unum Group in a report on Thursday. They set an “outperform” rating and a $91.00 price target for the company. Piper Sandler lifted their target price on shares of Unum Group from $74.00 to $82.00 and gave the company an “overweight” rating in a research note on Wednesday, December 18th. Barclays lifted their target price on shares of Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. Finally, Morgan Stanley lifted their target price on shares of Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Unum Group presently has an average rating of “Moderate Buy” and a consensus target price of $76.75.

Unum Group Price Performance

NYSE UNM opened at $75.01 on Friday. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $73.96 and a 200 day simple moving average of $63.76. The company has a market cap of $13.70 billion, a P/E ratio of 8.12, a P/E/G ratio of 1.07 and a beta of 0.81. Unum Group has a 1 year low of $46.39 and a 1 year high of $77.63.

Unum Group (NYSE:UNM) last posted its quarterly earnings data on Tuesday, October 29th. The financial services provider reported $2.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.10 by $0.03. The business had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.26 billion. Unum Group had a net margin of 13.76% and a return on equity of 15.21%. Unum Group’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.94 EPS. On average, sell-side analysts predict that Unum Group will post 8.54 EPS for the current year.

Unum Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 24th will be paid a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 2.24%. The ex-dividend date is Friday, January 24th. Unum Group’s payout ratio is currently 18.18%.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.